Position in JNJ
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$5,334,160,377
+$285,764,146 QoQ
Shares Held
21,821,962
-10.5% QoQ
Ownership
0.907%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 90.47906874734728.ToString("F0")%
Shared 0.5815700714720335.ToString("F0")%
None 8.939361181180685.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$1,820,720
PutShares
11,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $22,910,045,373 across 16 Drug Manufacturers - General names. JNJ ranks #1 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
21,821,962 | $5,334,160,377 | |
| 2 | LLY |
ELI LILLY & Co
|
4,860,408 | $4,470,457,455 | |
| 3 | ABBV |
AbbVie Inc.
|
13,278,161 | $2,887,867,228 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,713,363 | $2,251,030,425 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,053,151 | $2,097,957,640 | |
| 6 | PFE |
Pfizer Inc
|
53,879,900 | $1,512,947,580 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,301,337 | $1,413,226,077 | |
| 8 | AMGN |
Amgen Inc
|
3,793,443 | $1,334,722,908 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,334,160,377 | 21,821,962 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,048,396,231 | 24,394,280 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,568,312,862 | 24,637,649 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $3,635,832,323 | 23,802,503 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $3,844,579,817 | 23,182,464 | Shares | Other | 2025-04-29 | |
| 2024-12-31 | $2,652,313,728 | 18,339,882 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $3,379,116,617 | 20,851,022 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,170,873,083 | 21,694,534 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,503,112,005 | 22,144,965 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $3,483,853,074 | 22,226,956 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $3,411,211,106 | 21,901,837 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $1,820,720 | 11,000 | Put | Defined | 2023-08-03 | |
| 2023-06-30 | $3,884,779,552 | 23,470,152 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $3,742,759,735 | 24,146,837 | Shares | Defined | 2023-05-09 | |
| 2023-03-31 | $1,705,000 | 11,000 | Put | Defined | 2023-05-09 | |
| 2022-12-31 | $5,357,048,143 | 30,325,775 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $5,153,333,476 | 31,545,871 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,685,215,359 | 32,027,578 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,683,836,273 | 32,070,396 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $5,399,068,070 | 31,560,578 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,152,216,117 | 31,902,267 | Shares | Other | 2021-11-18 | |
| 2021-06-30 | $5,416,929,435 | 32,881,689 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $5,232,743,916 | 31,839,026 | Shares | Other | 2021-05-13 | |
| 2020-09-30 | $4,515,535,010 | 30,330,031 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,229,863,367 | 30,077,959 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $4,169,551,355 | 31,797,082 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||